Alice Chen-Plotkin is a physician-scientist and Associate Professor of Neurology at the University of Pennsylvania, where she runs a research group studying neurodegeneration and treats patients with Parkinson’s disease. A Phi Beta Kappa graduate and English literature major at Harvard University, she started her scientific training at Oxford University as a Rhodes Scholar. She then returned to Harvard for medical school and neurology residency training at Massachusetts General Hospital and Brigham and Women’s Hospital. She has been a faculty member at the University of Pennsylvania since 2010. She is active in many Parkinson’s disease biomarker development efforts, most notably as member of the national steering committee for the National Institute of Neurological Disorders and Stroke (NIH-NINDS) Parkinson’s Disease Biomarker Program since 2012, chairing the steering committee in 2013. Her lab specializes in the use of large-scale unbiased screens to generate leads in Parkinson’s disease and other neurodegenerative diseases, as well as following these leads downstream in targeted mechanistic studies in cell culture and animal model systems. The ultimate goal of these studies is to translate bench-based findings originating from patient-derived materials, back into diagnostics or therapeutic targets for neurodegeneration.
Associate Professor of Neurology, University of Pennsylvania School of Medicine
12:00 pm at Van Andel Institute
Conference Room 2102/2102
For questions, please contact Kim Cousineau at 616.234.5684.